The Impact of COPD and Inhaled Corticosteroids on Major Adverse Cardiovascular Events in Populations with Cardiovascular-Kidney-Metabolic Conditions - Poll - MDSpire

The Impact of COPD and Inhaled Corticosteroids on Major Adverse Cardiovascular Events in Populations with Cardiovascular-Kidney-Metabolic Conditions

  • By

  • Anne E. Ioannides

  • Emily L. Graul

  • Constantinos Kallis

  • Upasana Tayal

  • Hana Müllerová

  • Jennifer K. Quint

  • March 4, 2026

  • 0 min

Share

Original Source(s)

The Impact of COPD and Inhaled Corticosteroids on Major Adverse Cardiovascular Events in Populations with Cardiovascular-Kidney-Metabolic Conditions

  • by Anne E. Ioannides, Emily L. Graul, Constantinos Kallis, Upasana Tayal, Hana Müllerová, Jennifer K. Quint

  • March 4, 2026

Related Content

Editorial: Cardiovascular Anthropometry For Large Scale Population Studies Volume II

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial